Medications Used Among Nonhospitalized Pregnant Women With COVID-19: A Prospective Individual Patient Data Meta-Analysis in Europe and North America.

ABSTRACT:

Aim

To estimate the prevalence of medication use in nonhospitalized pregnant women with COVID-19.

Methods

A prospective two-stage individual patient meta-analysis across 10 data sources in Europe and North America studied medication use among nonhospitalized pregnant women with COVID-19 between January 2020 and December 2022. Comparisons were made between medication use within 30 days pre- and post-COVID-19 diagnosis in this cohort and two comparator groups: pregnant women without COVID-19 and nonpregnant women with COVID-19. Prevalence estimates were pooled using a random-effects model stratified by trimester.

Results

50 335 nonhospitalized pregnant women with COVID-19 were identified. The pooled prevalence of antibacterial use in the third trimester was higher post-

SUBMITTER: de Bruin O 

PROVIDER: S-EPMC12741507 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature